Company Profiles

driven by the PitchBook Platform

Gemmus Pharma

Description

Developer of therapeutics for the treatment of influenza and other infectious diseases. The company develops GP1681, a non-peptidic eiconsanoid analog that is used for the treatment of influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. It is also developing EP2 and EP4 agonists for the treatment of influenza.

2007

Founded

PRIVATE

Status

1-10

Employees

Angel

Latest Deal Type

$1.2M

Latest Deal Amount

$7.98M

Total Amount Raised

Description

Developer of therapeutics for the treatment of influenza and other infectious diseases. The company develops GP1681, a non-peptidic eiconsanoid analog that is used for the treatment of influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. It is also developing EP2 and EP4 agonists for the treatment of influenza.

Website:

www.gemmuspharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

409 Illinois Avenue San Francisco, CA 94158United States +1 (415) 978-2151
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Gemmus Pharma's full profile, request a free trial.

Gemmus Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Gemmus Pharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Gemmus Pharma Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BlueTree Allied AngelsVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Life Science AngelsAngel GroupMinority000 0000000 0000
Tech Coast AngelsAngel GroupMinority000 0000000 0000
The Angels' ForumAngel GroupMinority000 0000000 0000
BlueTree Allied Angels Venture Capital
Individual Investor Angel (individual)
Life Science Angels Angel Group
Tech Coast Angels Angel Group
The Angels' Forum Angel Group

Gemmus Pharma Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Daryl Faulds Ph.DChief Executive Officer & Board Member
William Guilford Ph.DPresident, Board Member & Co-Founder
Jonathan RossChief Financial Officer
William HolsteinSenior Vice President, Business Development
Daryl Faulds Ph.D Chief Executive Officer & Board Member
William Guilford Ph.D President, Board Member & Co-Founder
Jonathan Ross Chief Financial Officer
William Holstein Senior Vice President, Business Development

Gemmus Pharma Board Members (4)

NameRepresentingRoleSinceContact
Info
Christopher Dunn MDSelfBoard Member000 0000
Daryl Faulds Ph.DGemmus PharmaChief Executive Officer & Board Member000 0000
Larry MillerSelfBoard Member000 0000
Marc Rubin MDSelfBoard Member000 0000
Christopher Dunn MD Board Member Self
Daryl Faulds Ph.D Chief Executive Officer & Board Member Gemmus Pharma
Larry Miller Board Member Self
Marc Rubin MD Board Member Self
Request full access to PitchBook